VEGFR2 expression and TGF-β signaling in initial and recurrent high-grade human glioma. (Q48853324)

16 February 2018

title

VEGFR2 expression and TGF-β signaling in initial and recurrent high-grade human glioma. (English)

1 reference

16 February 2018

Brenda L Coomber

3

0 references

author name string

Elizabeth A Kuczynski

series ordinal

1

1 reference

16 February 2018

Steven G Patten

series ordinal

2

1 reference

16 February 2018

publication date

6 October 2011

1 reference

16 February 2018

published in

Oncology

1 reference

16 February 2018

volume

81

1 reference

16 February 2018

issue

2

1 reference

16 February 2018

page(s)

126-134

1 reference

16 February 2018

TGFbeta signalling: a complex web in cancer progression

cites work

1 reference

Targeting the tumour vasculature: insights from physiological angiogenesis

21 January 2018

1 reference

Angiogenesis as a therapeutic target

21 January 2018

1 reference

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas

21 January 2018

1 reference

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

21 January 2018

1 reference

Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy

21 January 2018

1 reference

Novel anti-angiogenic therapies for malignant gliomas

21 January 2018

1 reference

Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.

21 January 2018

1 reference

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

21 January 2018

1 reference

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

21 January 2018

1 reference

Glioblastoma stem-like cells give rise to tumour endothelium.

21 January 2018

1 reference

Heterogeneity of Tie2 expression in tumor microcirculation: influence of cancer type, implantation site, and response to therapy

21 January 2018

1 reference

VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment.

21 January 2018

1 reference

VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis

21 January 2018

1 reference

Interaction between hex and GATA transcription factors in vascular endothelial cells inhibits flk-1/KDR-mediated vascular endothelial growth factor signaling

21 January 2018

1 reference

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape

21 January 2018

1 reference

High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.

21 January 2018

1 reference

Protein expression of Fas, Fas ligand, Bcl-2 and TGFbeta2 and correlation with survival in initial and recurrent human gliomas

21 January 2018

1 reference

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

21 January 2018

1 reference

Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.

21 January 2018

1 reference

Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas

21 January 2018

1 reference

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.

21 January 2018

1 reference

Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme

21 January 2018

1 reference

Morphometric analysis of CNS microvascular endothelium.

21 January 2018

1 reference

Quantitative morphology of human glioblastoma multiforme microvessels: structural basis of blood-brain barrier defect.

21 January 2018

1 reference

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.

21 January 2018

1 reference

Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience

21 January 2018

1 reference

Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases

21 January 2018

1 reference

Clinical end points in recurrent glioblastoma: are antiangiogenic agents friend or foe?

21 January 2018

1 reference

TGF-beta signaling in vascular biology and dysfunction

21 January 2018

1 reference

Transforming growth factor-beta 1-mediated inhibition of the flk-1/KDR gene is mediated by a 5'-untranslated region palindromic GATA site

21 January 2018

1 reference

The role of proteases in transforming growth factor-beta activation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000332849

1 reference

16 February 2018

PubMed ID

21985798

1 reference

16 February 2018